Patent: 6,644,305
Summary for Patent: 6,644,305
| Title: | Nasal inhaler |
| Abstract: | A nasal inhaler for introducing a substance to a nasal cavity of a user. The nasal inhaler comprises a chamber having an interior and an exterior, an outlet comprising an air exit passageway in flow communication with the interior of the chamber, a one-way air inlet valve in one-way flow communication with the interior of the chamber, and a dosage inlet passageway in flow communication with the interior of the chamber. A container includes a dispensing portion disposed in the dosage inlet passageway. In preferred embodiment, an adapter defines the dosage inlet passageway and is connected to the chamber. A mask also can be connected to the outlet. A method for dispensing a substance into the nasal cavity of the user comprises inserting the outlet into the nasal cavity, dispensing the substance into the chamber and inhaling through the outlet. A method for assembling a nasal inhaler assembly also is provided. |
| Inventor(s): | John Macrae, Martin Foley, Jerry Grychowski |
| Assignee: | Trudell Medical International |
| Application Number: | US09/834,037 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,644,305
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Medimmune, Llc | FLUMIST, FLUMIST QUAD | influenza vaccine live, intranasal | Suspension | 125020 | June 17, 2003 | ⤷ Start Trial | 2021-04-11 |
| Medimmune, Llc | FLUMIST, FLUMIST QUAD | influenza vaccine live, intranasal | Suspension | 125020 | February 29, 2012 | ⤷ Start Trial | 2021-04-11 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
